The case for screening in early life for ‘non-treatable’ disorders: ethics, evidence and proportionality. A report from the Health Council of the Netherlands-Reference-Cited by-同舟云学术

The case for screening in early life for ‘non-treatable’ disorders: ethics, evidence and proportionality. A report from the Health Council of the Netherlands

Published:2022-02-07 Issue:10 Volume:30 Page:1155-1158
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Kalkman Shona,Dondorp Wybo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

https://www.nature.com/articles/s41431-022-01055-4.pdf

Reference28 articles.

1. Jansen ME, Metternick-Jones SC, Lister KJ. International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents. Eur J Hum Genet. 2016;25:10–6.

2. Ross LF. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy. Am J Med Genet A. 2006;140:914–22.

3. Bailey DB Jr., Beskow LM, Davis AM, Skinner D. Changing perspectives on the benefits of newborn screening. Ment Retard Dev Disabil Res Rev. 2006;12:270–9.

4. EURORDIS. The Voice of Rare Disease Patients in Europe. Key principles for newborn screening. Brussels: EURORDIS. https://eurordis.org/newbornscreening 2021.

5. Alexander D, van Dyck PC. A vision of the future of newborn screening. Pediatrics 2006;117:S350–4.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023);International Journal of Neonatal Screening;2024-05-23

2. Ethical Aspects of Pediatric Genetic Care;Pediatric Clinics of North America;2023-10

3. Happy 30th birthday to the European Journal of Human Genetics!;European Journal of Human Genetics;2022-10

4. Exome/Genome-Wide Testing in Newborn Screening: A Proportionate Path Forward;Frontiers in Genetics;2022-07-04